These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11440290)

  • 1. A pharmacokinetic evaluation of 0.5% and 5% fluorouracil topical cream in patients with actinic keratosis.
    Levy S; Furst K; Chern W
    Clin Ther; 2001 Jun; 23(6):908-20. PubMed ID: 11440290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis.
    Loven K; Stein L; Furst K; Levy S
    Clin Ther; 2002 Jun; 24(6):990-1000. PubMed ID: 12117087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis.
    Jorizzo J; Stewart D; Bucko A; Davis SA; Espy P; Hino P; Rodriguez D; Savin R; Stough D; Furst K; Connolly M; Levy S
    Cutis; 2002 Dec; 70(6):335-9. PubMed ID: 12502122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, Safety, and Tolerability of 4% 5-Fluorouracil Cream in a Novel Patented Aqueous Cream Containing Peanut Oil Once Daily Compared With 5% 5-Fluorouracil Cream Twice Daily: Meeting the Challenge in the Treatment of Actinic Keratosis.
    Dohil MA
    J Drugs Dermatol; 2016 Oct; 15(10):1218-1224. PubMed ID: 27741339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel 0.5% fluorouracil cream is minimally absorbed into the systemic circulation yet is as effective as 5% fluorouracil cream.
    Levy S; Furst K; Chern W
    Cutis; 2002 Aug; 70(2 Suppl):14-21. PubMed ID: 12353676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorouracil 5% and 0.5% creams for the treatment of actinic keratosis: equivalent efficacy with a lower concentration and more convenient dosing schedule.
    Jorizzo JL; Carney PS; Ko WT; Robins P; Weinkle SH; Werschler WP
    Cutis; 2004 Dec; 74(6 Suppl):18-23. PubMed ID: 15666898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks.
    Weiss J; Menter A; Hevia O; Jones T; Ling M; Rist T; Roberts J; Shavin JS; Sklar J; Webster G; Connolly M; Furst K; Levy S
    Cutis; 2002 Aug; 70(2 Suppl):22-9. PubMed ID: 12353677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the skin permeation of three topical 0.5% fluorouracil formulations with that of a 5% formulation.
    Levy S; Furst K; Chern W
    Clin Ther; 2001 Jun; 23(6):901-7. PubMed ID: 11440289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inflammatory effect of systemic fluorouracil in actinic keratosis.
    Nabai H; Mohindra R; Mehregan D
    Cutis; 1999 Jul; 64(1):43-4. PubMed ID: 10431671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-week treatment with 0.5% fluorouracil cream prior to cryosurgery in patients with actinic keratoses: a double-blind, vehicle-controlled, long-term study.
    Jorizzo J; Weiss J; Vamvakias G
    J Drugs Dermatol; 2006 Feb; 5(2):133-9. PubMed ID: 16485881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial.
    Jorizzo J; Weiss J; Furst K; VandePol C; Levy SF
    Arch Dermatol; 2004 Jul; 140(7):813-6. PubMed ID: 15262691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy.
    Couch SM; Custer PL
    Ophthalmic Plast Reconstr Surg; 2012; 28(3):181-3. PubMed ID: 22460673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
    Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
    JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of topical fluorouracil to treat actinic keratosis.
    Robins P; Gupta AK
    Cutis; 2002 Aug; 70(2 Suppl):4-7. PubMed ID: 12353679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical treatment of actinic keratosis with fluorouracil: is irritation associated with efficacy?
    Jorizzo J
    J Drugs Dermatol; 2004; 3(1):21-6. PubMed ID: 14964743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-week treatment with once-daily fluorouracil cream 0.5% in participants with actinic keratoses.
    Menter A; Vamvakias G; Jorizzo J
    Cutis; 2008 Jun; 81(6):509-16. PubMed ID: 18666394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of actinic keratoses in the United States with topical fluorouracil: a pharmacoeconomic evaluation.
    Gupta AK
    Cutis; 2002 Aug; 70(2 Suppl):30-6. PubMed ID: 12353678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of 0.5% colchicine cream versus 5% 5-fluorouracil cream in the treatment of cutaneous field cancerization: a randomized clinical trial.
    Teixeira AS; Martins IMC; Miola AC; Miot HA
    An Bras Dermatol; 2024; 99(4):527-534. PubMed ID: 38614940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical application of 5-fluorouracil 5 percent cream associated with severe neutropenia: discussion of a case and review of systemic reactions after topical treatment with 5-fluorouracil.
    Cohen PR
    Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29906006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity of Local Skin Reactions During 5-Fluorouracil Treatment Related to the Number of Actinic Keratosis Lesions: A Post Hoc, Exploratory Analysis.
    Stockfleth E; Bégeault N; Delarue A
    Dermatol Ther (Heidelb); 2022 Feb; 12(2):467-479. PubMed ID: 34954811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.